Calley Means on the 'Sick Care' Model: warns against

Calley Means says the U.S. healthcare system is really a “sick care” system — a pharmaceutical treadmill that pushes drugs instead of long-term wellness — and argues that disease rates rise as more drugs are prescribed. The New York Times’ reporting on his HHS role, summarized via Conservative Brief, captured this as the core of his critique.

His stated reasoning: the system profits from managing disease rather than preventing it, so its incentives point toward more prescriptions, not better metabolic health. In his framing, rising chronic-disease rates alongside rising prescription rates are not a coincidence but a feature of the business model.

The position underpins his broader policy agenda — redirecting the $4.5T spend toward prevention, HSA flexibility for lifestyle interventions, and patient choice — and it is one of the reasons his critiques resonate beyond the food portfolio into the pharmaceutical side of the MAHA platform.

What Means says

• Means says the U.S. system pushes drugs instead of long-term wellness.
• He says disease rates rise as more drugs are prescribed.
• He frames the pharmaceutical treadmill as a business model that profits from managing disease rather than preventing it.

This page chronicles a stated position of the person above. It is not medical advice and not the site's own conclusion.